8-K: Current report filing
Published on November 5, 2008
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): November 1, 2008
APOLLO
MEDICAL HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
000-25809
|
20-8046599
|
|
(State
or Other Jurisdiction
|
(Commission
File
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
Number)
|
Identification
Number)
|
1010
N.
Central Avenue, Suite 201, Glendale, CA 91202
(Address
of principal executive offices) (zip code)
(818)
507-4617
(Registrant's
telephone number, including area code)
Copies
to:
Andrea
Cataneo, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway
New
York,
New York 10006
Phone:
(212) 930-9700
Fax:
(212) 930-9725
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Effective
November 1, 2008, Suresh T. Nihalani was appointed as a director of Apollo
Medical Holdings, Inc. (the “Company”). There is no family relationship between
Mr. Nihalani and any director, executive officer or person nominated or chosen
by the Company to become a director or executive officer. In connection with
his
appointment, the board of directors approved the issuance of up to 400,000
shares of the Company’s common stock to Mr. Nihalani. Such shares shall vest at
a rate of 1/36th
per
month during Mr. Nihalani’s term as a director. In addition, Mr. Nihalani shall
receive $1,000 for each meeting of the board of directors and $1,200 per day
for
any time Mr. Nihalani is required to travel out-of-town on behalf of the
Company.
Mr.
Nihalani served as President and Chief Executive Officer of Airtera Inc. from
June 2007 through August 2008. Prior to joining Airtera, Mr. Nihalani served
as
President and Chief Executive Officer of ClearMesh Networks Inc. In addition,
Mr. Nihalani served as President and Chief Executive Officer of Nevis Networks
Inc. from October 2002 through April 2005. Mr. Nihalani is 56 years
old.
Item
9.01 Financial Statements and Exhibits
(a)
Financial statements of business acquired.
Not
applicable.
(b)
Pro
forma financial information.
Not
applicable.
Not
applicable.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
APOLLO
MEDICAL HOLDINGS, INC.
|
||
| |
|
|
|
Dated:
November 4, 2008
|
By: |
/s/
Warren Hosseinion
|
|
Name:
Warren Hosseinion
Title:
Chief
Executive Officer
|
||